Enbridge Inc
ENB
TC Energy Corp
TRP
The Toronto-Dominion Bank
TD
TELUS Corp
T
Emera Inc
EMA
CA Stock MarketDetailed Quotes
MDMA Pharmala Biotech Holdings Inc
- 0.300
- +0.005+1.69%
15min DelayPost Market Jan 7 15:59 ET
28.29MMarket Cap-30.00P/E (TTM)
0.310High0.275Low577.23KVolume0.290Open0.295Pre Close161.47KTurnover0.35052wk High0.61%Turnover Ratio94.29MShares0.06552wk Low-0.01EPS TTM28.29MFloat Cap0.540Historical HighLossP/E (Static)94.29MShs Float0.020Historical Low-0.01EPS LYR11.86%Amplitude--Dividend TTM14.29P/B1Lot Size--Div YieldTTM
Pharmala Biotech Holdings Inc Key Stats
Quarterly+Annual
YOY
| (FY)Aug 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 94.60%1.04M | -3.13%90.42K | 752.47K | 581.44%532K | 5,712.48%438.67K | 0 | 93.34K | 0 | 78.07K | 7.55K |
| Operating revenue | 94.60%1.04M | -3.13%90.42K | --752.47K | 581.44%532K | 5,712.48%438.67K | --0 | --93.34K | --0 | --78.07K | --7.55K |
| Cost of revenue | 89.79%147.86K | 0 | 292.96K | 3,304.90%77.9K | 17,850.23%77.9K | 0 | 0 | 0 | 2.29K | 434 |
| Gross profit | 95.43%887.44K | -3.13%90.42K | 459.51K | 499.22%454.1K | 4,971.90%360.76K | 0 | 93.34K | 0 | 75.78K | 7.11K |
| Operating expense | 25.80%1.53M | 0.57%312.99K | -12.10%253.61K | 14.67%1.22M | 36.87%271.77K | 23.29%338.74K | 9.07%311.22K | -4.70%288.5K | -57.70%1.06M | 198.56K |
| Selling and administrative expenses | 4.15%1.2M | -2.72%236.42K | -28.62%176.99K | 25.46%1.15M | 115.49%354.24K | 17.17%300.07K | -3.59%243.03K | 0.90%247.95K | -62.81%918.28K | --164.39K |
| -General and administrative expense | 4.15%1.2M | -2.72%236.42K | -28.62%176.99K | 25.46%1.15M | 115.49%354.24K | 17.17%300.07K | -3.59%243.03K | 0.90%247.95K | -62.81%918.28K | --164.39K |
| Research and development costs | 175.24%125.29K | --32.17K | --41.67K | ---166.52K | ---- | ---- | --0 | --0 | --0 | ---- |
| Depreciation amortization depletion | 33.06%70.21K | 19.72%15.78K | 19.84%15.79K | 334.82%52.77K | 20.37%13.23K | 2,861.35%13.18K | 2,861.35%13.18K | 5,108.70%13.18K | 3,904.95%12.14K | --10.99K |
| -Depreciation and amortization | 33.06%70.21K | 19.72%15.78K | 19.84%15.79K | 334.82%52.77K | 20.37%13.23K | 2,861.35%13.18K | 2,861.35%13.18K | 5,108.70%13.18K | 3,904.95%12.14K | --10.99K |
| Other operating expenses | -24.09%135.65K | -47.98%28.62K | -30.03%19.16K | 36.47%178.71K | 205.52%70.82K | 39.96%25.5K | 67.63%55.01K | -51.75%27.38K | 230.66%130.95K | --23.18K |
| Operating profit | 15.65%-643.57K | -2.15%-222.57K | 171.37%205.91K | 22.59%-762.95K | 146.49%89K | -64.37%-338.74K | 23.64%-217.89K | 4.70%-288.5K | 60.72%-985.58K | -191.45K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | -967.60%-180.03K | -169.43K | -16.86K | -169.3K | 145.62K | |||||
| Special income (charges) | -34.02%-22.6K | ---- | ---- | ---16.86K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Write off | 34.02%22.6K | ---- | ---- | --16.86K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---157.43K | ---- | ---169.43K | ---- | ---- | ---- | --145.62K | ---- | ---- | ---- |
| Income before tax | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | 58.06%-80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K | -191.45K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | 58.06%-80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K | -191.45K |
| Net income continuous operations | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | 58.06%-80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K | ---191.45K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | 58.06%-80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K | -191.45K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | 58.06%-80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K | -191.45K |
| Diluted earnings per share | 0.00%-0.01 | -194.03%-0.0026 | 112.14%0.0004 | 0.00%-0.01 | 0 | -64.36%-0.0041 | 74.67%-0.0009 | 4.69%-0.0035 | 66.92%-0.01 | 0 |
| Basic earnings per share | 0.00%-0.01 | -194.03%-0.0026 | 112.14%0.0004 | 0.00%-0.01 | 0 | -64.36%-0.0041 | 74.67%-0.0009 | 4.69%-0.0035 | 66.92%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.